You are here: Industry Insights > COVID-19

News List

Study indicates lockdown significantly reduced coronavirus pharmatimes
July 15, 2020
The largest study to date examining rates of coronavirus infection in the general public has found that there was a significant reduction of the virus before lockdown restrictions were eased.
Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators worldpharmanews
July 15, 2020
Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment ...
Regeneron, NIAID Begin REGN-COV2 Phase 3 COVID-19 Prevention Trial americanpharmaceuticalreview
July 15, 2020
Regeneron Pharmaceuticals announced the initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron's investigational double antibody cocktail for the treatment and prevention of COVID-19.
Mylan Secures Regulatory Approval for Remdesivir Lyophilized Powder for Injection in India americanpharmaceuticalreview
July 15, 2020
Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in India as part of the DCGI's accelerated approval process to address urgent, unmet needs amid the evolving ...
FDA Authorizes Additional COVID-19 Combination Test Ahead of Flu Season americanpharmaceuticalreview
July 15, 2020
The U.S. Food and Drug Administration (FDA) further assisted health care providers around the country prepare for the upcoming flu season during the COVID-19 pandemic by issuing an emergency use authorization (EUA) for the third diagnostic test for ...
Oral bacteriotherapy improved outcomes in COVID-19 patients europeanpharmaceuticalreview
July 15, 2020
Clinical trial testing a live biotherapeutic in hospitalised COVID-19 patients suggests the bacteriotherapy could be promising.
UK researchers engineer antibodies from llamas against Covid-19 pharmaceutical-technology
July 15, 2020
Researchers from the Rosalind Franklin Institute, Oxford University, Diamond Light Source and Public Health England in the UK have engineered antibodies obtained from llamas against Covid-19.
Luina Bio and XING Technologies Partner on SARS-CoV-2 Diagnostic Kit contractpharma
July 15, 2020
To co-develop and manufacture new and fast SARS-CoV-2 diagnostic kit based on a temperature-stable molecule utilizing XING patented technology.
Operation Warp Speed to start making COVID-19 vaccine by end of summer, says U.S. official expresspharma
July 15, 2020
He added that the administration is already working with companies to equip and outfit manufacturing facilities and acquire raw materials.
Biophore ramps up Made-In-India Favipiravir production for Covid-19 expresspharma
July 15, 2020
Biophore has received the DCGI license to manufacture the API in India and has been cleared for export as well.